0%
Revolutionary Below-the-Knee (BTK) Treatment for Chronic Limb-Threatening Ischemia (CLTI) in Conjunction with Drug-Coated Balloon (DCB).
Interested in ordering the Spur, retrievable scaffold system? Get in touch for a quote, clinical brochure, or to arrange a product demo.
Indications for Use: The Spur is indicated for treatment of de novo or restenotic infrapopliteal lesions, with reference vessel diameters ranging from 2.5 – 4.5mm, prior to treatment with a commercially available drug coated balloon.
Intended Use: Treatment of de novo or restenotic lesions in the infrapopliteal arteries.
Design Features:
Self-expanding stent with radial spikes designed to create channels in the vessel wall.
Retrievable stent therapy (RST) allowing for stent removal after use.
Procedure: Stent is deployed to modify the lesion and enhance drug absorption. Stent is then recaptured and removed. Followed by treatment with a commercially available drug-coated balloon (DCB).
Regulatory Status: CE Mark certified in the European Union as a Class IIa medical device under the EU Medical Device Regulation (2017/745) Full Specs
